Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Chanderdeep Singh

Thoracic Surgery (Cardiothoracic Vascular Surgery) Utica, NY Medical Doctor

NPI 1447251889 CMS profile 1144835

2209 Genesee St, Utica, NY 13501

Open in the dashboard

General payments

$14,424

338 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$242,245 paid to institutions, not to them · program years 2020–2023

Through program year 2025, Chanderdeep Singh of Utica, NY is reported in the CMS Open Payments database as having received $14,424 across 338 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $242,245 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 74th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $668 17
2024 General $960 34
2023 General $3,337 89
2022 General $1,588 53
2021 General $531 20
2020 General $2,756 45
2019 General $4,585 80

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Chanderdeep Singh
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Chanderdeep Singh were reported at $668. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Chanderdeep Singh Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $4,585 $886 $178–$3,167 $163
2020 $2,756 $341 $108–$1,605 $114
2021 $531 $453 $125–$1,886 $132
2022 $1,588 $695 $180–$2,566 $149
2023 $3,337 $745 $205–$2,662 $160
2024 $960 $799 $214–$2,967 $164
2025 $668 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $4,939 176 payments
  2. Atricure, Inc. $4,183 32 payments
  3. Medtronic Vascular, Inc. $1,776 6 payments
  4. Abiomed $740 13 payments
  5. Abbott Laboratories $415 6 payments
  6. Chiesi USA, Inc. $301 13 payments
  7. Zimmer Biomet Holdings, Inc. $274 8 payments
  8. Baxter Healthcare $208 10 payments
  9. Boston Scientific Corporation $156 7 payments
  10. Amgen Inc. $128 8 payments
  11. Other $1,305 59 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,101 330 payments
  2. Travel and Lodging $4,323 8 payments
Products named General payments · program years 2019–2025
  1. EPI-SENSE GUIDED COAGULATION SYS $2,061 8 payments
  2. Octopus $1,659 5 payments
  3. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $679 13 payments
  4. Impella $482 11 payments
  5. ATRICURE ATRICLIP LAA EXCLUSION $360 3 payments
  6. INSPIRIS RESILIA AORTIC VALVE Pericardial Heart Valves $306 2 payments
  7. CLEVIPREX $195 6 payments
  8. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $188 11 payments
  9. INSPIRIS RESILIA aortic valve Pericardial Heart Valves $176 2 payments
  10. SYNERGY ABLATION SYSTEM $153 1 payment
  11. Other $3,268 140 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$42,390

Medicare's payments for the services billed

Medicare patients

56

Average age 76

Services billed

87

25 women, 31 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 66%
Diabetes 52%
Arthritis 46%
Atrial fibrillation 45%
Chronic kidney disease 32%
COPD 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

338 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record